Huang CS, Yang Y, Kwong A, Chen SC, Tseng LM, Liu MC, Shen K, Wang S, Ng TY, Feng Y, Sun G, Yan IR, Shao Z. Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study. Breast Cancer Res Treat. 2021 Jun;187(3):759-768. doi: 10.1007/s10549-021-06166-y. Epub 2021 Apr 15. PMID: 33860389.

Shao Z, Tseng LM, Huang CS, Pang D, Yang Y, Li W, Liao N, Geng C, Zhang Q, Xu B, Liu D, Kwong A; et al (continued in the appendix). Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study. Jpn J Clin Oncol. 2021 Mar 3;51(3):345-353. doi: 10.1093/jjco/hyaa216. PMID: 33619550.

Huang KC, Huang CS, Su MY, Hung CL, Ethan Tu YC, Lin LC, Hwang JJ. Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements. JACC Cardiovasc Imaging. 2021 Feb;14(2):335-345. doi: 10.1016/j.jcmg.2020.08.034. Epub 2020 Nov 18. PMID: 33221213.

Lee YW, Huang CS, Shih CC, Chang RF. Axillary lymph node metastasis status prediction of early-stage breast cancer using convolutional neural networks. Comput Biol Med. 2021 Mar;130:104206. doi: 10.1016/j.compbiomed.2020.104206. Epub 2020 Dec 31. PMID: 33421823.

Lee YW, Huang CS, Shih CC, Chang RF. Axillary lymph node metastasis status prediction of early-stage breast cancer using convolutional neural networks. Comput Biol Med. 2021 Mar;130:104206. doi: 10.1016/j.compbiomed.2020.104206. Epub 2020 Dec 31. PMID: 33421823.

Hurvitz SA, Martin M, Press MF, Chan D, Fernandez-Abad M, Petru E, Rostorfer R, Guarneri V, Huang CS, Barriga S, Wijayawardana S, Brahmachary M, Ebert PJ, Hossain A, Liu J, Abel A, Aggarwal A, Jansen VM, Slamon DJ. Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer. Clin Cancer Res. 2020 Feb 1;26(3):566-580. doi: 10.1158/1078-0432.CCR-19-1425. Epub 2019 Oct 15. PMID: 31615937; PMCID: PMC7498177.

Lin PH, Chen M, Tsai LW, Lo C, Yen TC, Huang TY, Chen CK, Fan SC, Kuo SH, Huang CS. Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer. Cancer Sci. 2020 Apr;111(4):1375-1384. doi: 10.1111/cas.14313. Epub 2020 Feb 19. PMID: 31958182; PMCID: PMC7156820.

Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Børresen-Dale AL, Brauch H, Brenner H, Brucker SY, Burwinkel B, Caldas C, Canzian F, Chang-Claude J, Chanock SJ, Chin SF, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Devilee P, Dunn JA, Dunning AM, Dwek M, Earl HM, Eccles DM, Eliassen AH, Ellberg C, Evans DG, Fasching PA, Figueroa J, Flyger H, Gago-Dominguez M, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Giles GG, Goldgar DE, González-Neira A, Grip M, Guénel P, Guo Q, Haiman CA, Håkansson N, Hamann U, Harrington PA, Hiller L, Hooning MJ, Hopper JL, Howell A, Huang CS, Huang G, Hunter DJ, Jakubowska A, John EM, Kaaks R, Kapoor PM, Keeman R, Kitahara CM, Koppert LB, Kraft P, Kristensen VN, Lambrechts D, Le Marchand L, Lejbkowicz F, Lindblom A, Lubiński J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Maurer T, Mavroudis D, Meindl A, Milne RL, Mulligan AM, Neuhausen SL, Nevanlinna H, Newman WG, Olshan AF, Olson JE, Olsson H, Orr N, Peterlongo P, Petridis C, Prentice RL, Presneau N, Punie K, Ramachandran D, Rennert G, Romero A, Sachchithananthan M, Saloustros E, Sawyer EJ, Schmutzler RK, Schwentner L, Scott C, Simard J, Sohn C, Southey MC, Swerdlow AJ, Tamimi RM, Tapper WJ, Teixeira MR, Terry MB, Thorne H, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Turnbull C, Vachon CM, van der Kolk LE, Wang Q, Winqvist R, Wolk A, Yang XR, Ziogas A, Pharoah PDP, Hall P, Wessels LFA, Chenevix-Trench G, Bader GD, Dörk T, Easton DF, Canisius S, Schmidt MK. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nat Commun. 2020 Jan 16;11(1):312. doi: 10.1038/s41467-019-14100-6. PMID: 31949161; PMCID: PMC6965101.

Chen CH, Lu YS, Cheng AL, Huang CS, Kuo WH, Wang MY, Chao M, Chen IC, Kuo CW, Lu TP, Lin CH. Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations. Oncologist. 2020 Jan;25(1):e16-e23. doi: 10.1634/theoncologist.2019-0123. Epub 2019 Aug 1. PMID: 31371522; PMCID: PMC6964121.

Moon WK, Huang YS, Hsu CH, Chang Chien TY, Chang JM, Lee SH, Huang CS, Chang RF. Computer-aided tumor detection in automated breast ultrasound using a 3-D convolutional neural network. Comput Methods Programs Biomed. 2020 Jul;190:105360. doi: 10.1016/j.cmpb.2020.105360. Epub 2020 Jan 25. PMID: 32007838.